PAVURUTAMAB

UNII:	GLR3JG8TZU
Formula:
Preferred Substance Name:	PAVURUTAMAB

2250292-39-6
AMG701
AMG-701
ANTI-BCMA X ANTI-CD3 BITE (BISPECIFIC T CELL ENGAGER) ANTIBODY CONSTRUCT
ANTI-BCMA X ANTI-CD3 BITE AMG 701
ANTI-BCMA/CD3 BITE ANTIBODY AMG 701
BCMA/CD3-DIRECTED BISPECIFIC T-CELL ENGAGER ANTIBODY AMG 701
IMMUNOGLOBULIN, ANTI-(HUMAN TUMOR NECROSIS FACTOR RECEPTOR SUPERFAMILY PROTEIN TNFRSF17) (HUMAN MONOCLONAL BRA-HWZV 1 SINGLE-CHAIN VARIABLE FRAGMENT VH1-(GGGGS)3-VL1) FUSION PROTEIN WITH PEPTIDE LINKER (GGGGS) FUSION PROTEIN WITH IMMUNOGLOBULIN ANTI-(HUMAN CD3 ANTIGEN .EPSILON.-CHAIN) (HUMAN MONOCLONAL BRA-HWZV 1 SINGLE-CHAIN VARIABLE FRAGMENT VH2-(GGGGS)3-VL2) FUSION PROTEIN WITH FUSION PROTEIN WITH PEPTIDE LINKER (GGGG) FUSION PROTEIN WITH IMMUNOGLOBULIN G1 (HUMAN .GAMMA.1-CHAIN C-REGION C-TERMINAL FRAGMENT) FUSION PROTEIN WITH PEPTIDE LINKER (GGGGS)6 FUSION PROTEIN WITH IMMUNOGLOBULIN G1 (HUMAN .GAMMA.1-CHAIN C-REGION C-TERMINAL FRAGMENT)
PAVURUTAMAB [INN]
PAVURUTAMAB [USAN]
PAVURUTAMAB [WHO-DD]

Note

UNIIs are generated based on scientific identity characteristics using ISO 11238 data elements. UNII availability does not imply any regulatory review or approval. Synonyms and mappings are based on the best public information available at the time of publication. Please report any problems/errors associated with this data to FDA-SRS@fda.hhs.gov.

PAVURUTAMAB

Synonyms and Mappings

Resources